about
Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma ModelThe late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis.Langerhans cells as targets for immunotherapy against skin cancer.Langerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin.Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signallingLangerhans cells cross-present antigen derived from skinThe role of the e3 ligase cbl-B in murine dendritic cells.The late endosomal adaptor molecule p14 (LAMTOR2) regulates TGFβ1-mediated homeostasis of Langerhans cellsEpidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis.Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.Langerhans cells - dendritic cells of the epidermis.Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responsesEpidermal Langerhans cells--changing views on their function in vivo.Langerhans cells in the sebaceous gland of the murine skin.Targeting skin dendritic cells to improve intradermal vaccination.Monitoring Skin Dendritic Cells in Steady State and Inflammation by Immunofluorescence Microscopy and Flow Cytometry.Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis.Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors.Cytip regulates dendritic-cell function in contact hypersensitivity.The lymph vessel network in mouse skin visualised with antibodies against the hyaluronan receptor LYVE-1.Ontogeny of Langerin/CD207 expression in the epidermis of mice.Tumor immunotherapy by epicutaneous immunization requires langerhans cells.Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.Migratory Langerhans cells in mouse lymph nodes in steady state and inflammationConditioning of the injection site with CpG enhances the migration of adoptively transferred dendritic cells and endogenous CD8+ T-cell responsesE-Cadherin is Dispensable to Maintain Langerhans Cells in the EpidermisOncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
P50
Q28607232-CB878B04-22B9-4299-BC97-87EFA6887EDEQ30564030-670620A3-7CCF-49E6-91E5-91BBBD97CE92Q34009436-6D87C966-A892-414E-A45E-F3CC96A9E45AQ34130289-B70610A5-2320-4261-AE08-3EC820E2DCB6Q34342500-F7F9F8CE-F6A3-4F5C-AE15-2D619262A40AQ34453798-3805B35E-9B27-4715-AE5B-A81406392A0DQ34650867-9DB0998A-E19F-40B4-86C2-200451B6BC86Q34769671-251893BA-C016-48E6-BCF0-54806C59198CQ34848338-C7C574FD-C774-4003-B025-8F550D831F52Q35119724-F4A54D52-4B72-4A23-A24B-8F023E8E64DFQ35138155-95571894-BAAF-4D55-B3D9-BCFE401F6790Q35219303-76536FAA-3DBC-4290-93E4-C654AB9FC2AAQ35785681-589B7636-6C07-4045-8454-38CEB1E3AB3DQ36530941-1B419CA0-D189-4F72-BBE5-59E6DCC68FD7Q36908571-BA438DA7-5273-45AF-80FF-F9E93A264362Q37831193-118A0532-6976-419B-8D31-F4D28B1B75E2Q38403442-AF2182A0-0D08-4E71-B630-02855BB3E6C6Q39843059-90D47948-099C-443A-BDB4-50A897958D9BQ40277855-C4E34E68-CA0A-470F-9409-E64524D07018Q42106951-F46959B6-993A-49DE-8FA0-83314B5B2040Q42426613-7851285E-B9EB-4845-8135-50FA78983E97Q46313243-9DBCF3B8-7925-42B1-934C-ABE3DA5BEEE7Q47758459-006D9F33-C4DE-48A6-9F4F-C5376A5718F9Q50649335-F7F2354A-0FE9-427F-A208-B18BE3369A43Q50768287-C9CFB722-D20B-4031-BA30-7E63C40BA035Q52588439-92BAE18D-2EF3-453B-A858-AA2DC7F9E8EDQ81896151-A293406E-967B-4902-9388-193EA5630778Q82849035-12385381-6ED1-4D6A-9969-F18C576D9443Q91510701-27438C9C-73D0-4D41-A3B4-9FD7EBC395C4Q93018018-2F37D930-8E52-4313-BB27-0B09DCFAE8E3
P50
description
researcher
@en
wetenschapper
@nl
name
Christoph H Tripp
@en
Christoph H Tripp
@nl
type
label
Christoph H Tripp
@en
Christoph H Tripp
@nl
prefLabel
Christoph H Tripp
@en
Christoph H Tripp
@nl
P106
P31
P496
0000-0001-5502-7241